Related Experiment Videos

[Pulmonary abcess, a revision]

Ana Moura Gonçalves1, Luiz Menezes Falcão, Luciano Ravara

  • 1Interna do Internato Complementar de Medicina Interna, no Hospital de Santa Maria, Lisboa, Portugal. anapmgoncalves@gmail.com

Revista Portuguesa De Pneumologia
|February 13, 2008
PubMed

Insights

Lung abscesses are lung infections causing tissue destruction. Risk factors include chronic lung disease, aspiration, and altered mental status, with antimicrobial resistance posing a challenge.

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Microbiology

Context:

  • Lung abscesses are cavitating lesions resulting from microbial infections.
  • Certain patient populations face elevated risks, including those with chronic lung disease, bronchial obstruction, or aspiration risks.

Purpose:

  • To review the bacteriological characteristics, diagnosis, therapy, and prognosis of lung abscesses.
  • To address the growing concern of antimicrobial resistance in treating these infections.

Summary:

  • Lung abscesses are characterized by necrotic debris within cavitating lesions, primarily caused by microbial agents.
  • Key risk factors encompass chronic lung conditions, bronchial obstruction (e.g., from cancer), aspiration events (linked to alcoholism or altered mental status), and anatomical or physiological abnormalities of the upper aerodigestive tract.
  • The review covers essential aspects including bacteriology, diagnostic approaches, therapeutic strategies, and prognostic indicators, while also acknowledging the challenge of antimicrobial resistance.

Impact:

  • Informing clinicians about high-risk patient groups for early detection and intervention.
  • Highlighting the importance of understanding bacteriological profiles for effective treatment selection.
  • Emphasizing the need for strategies to combat antimicrobial resistance in lung abscess management.

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Atelectasis II: Pathophysiology01:10

Atelectasis II: Pathophysiology

Atelectasis develops when alveoli lose their air and collapse inward. Because lung tissue is naturally elastic, these air sacs shrink rather than remaining open. Collapsed alveoli are no longer ventilated, reducing their role in gas exchange. Blood flow may continue in these regions, creating a ventilation–perfusion mismatch. Clinical findings include decreased breath sounds, dullness to percussion, reduced chest expansion, and decreased tactile fremitus as sound transmission through collapsed...